Website: lectenz.com   |   LinkedIn: linkedin.com/company/lectenz_bio

Glycoscience Made Simple

How Lectenz Bio is engineering enzymes into precise, reliable tools for studying glycans

At a glance

  • Company: Lectenz Bio (lectenz.com)
  • Headquarters: Athens, Georgia
  • Focus: Glyco-research and bioprocessing tools: glycan detection reagents, chromatography kits, enzymes, and molecular biology reagents
  • Platforms: Patented Lectenz® and GlycoSense™ technologies
  • Working with PSG on: HubSpot, and sales and business development scaling

Why glycans matter, and why they’re so hard to study

Glycans, the complex sugar chains that coat cells and proteins, are some of biology’s most important signals. They sit on cell surfaces where cells first make contact with each other, the immune system, and pathogens. And they change in disease: shifts in sialylation and fucosylation are linked to cancers such as prostate and pancreatic cancer, and to autoimmune conditions such as rheumatoid arthritis.

That makes glycans powerful biomarkers and critical quality attributes for biotherapeutics. But they’re notoriously hard to detect. They’re highly branched, variably linked, and the plant lectins traditionally used to study them often suffer from cross-reactivity, unclear specificity, and lot-to-lot variability.

The Lectenz® solution: enzymes reimagined as binders

Lectenz Bio started with a clever insight. Carbohydrate-processing enzymes already recognize their sugar targets with exquisite specificity. Engineer out the cutting, keep the recognition, and you get a reagent that binds glycans precisely.

Using structure-guided protein engineering and directed evolution, the team converts glycan-processing enzymes and glycan-binding proteins into high-affinity reagents called Lectenz®, because they behave like lectins but keep the specificity of enzymes.

  • Precisely defined specificity, with the ability to distinguish glycan linkages that conventional lectins can’t
  • Tunable binding properties tailored to the application
  • Consistent, recombinant production that eliminates lot-to-lot variability
  • Low toxicity compared with plant-derived lectins
  • Versatile formats for western blotting, histology, flow cytometry, affinity purification, and chromatography

Products researchers can use today

  • SiaFind™ detection reagents: flagship Lectenz® reagents for detecting sialylated glycans, including linkage-specific options
  • Glycan enrichment and chromatography kits for glycoproteomics and glycomics workflows
  • Enzymes and molecular biology reagents to round out glycobiology workflows
  • Pipeline innovations including fucose-specific and pan-N-glycan reagents

Backed by NIH

Lectenz Bio’s science has earned sustained support through multiple NIH Small Business Innovation Research awards across the National Cancer Institute, NIGMS, and the Office of Research Infrastructure Programs. The company has also been featured in NIH’s portfolio company showcases at BIO.